Author

Zhizhen Zhu

Observed name: ZHU Zhizhen

Institution: Chinese People's Liberation Army

Observed institution: Chinese People's Liberation Army

OpenAlex ID: A5111231537

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

2025 · Hani M. Babiker, Vincent Picozzi, et al. · Journal of Clinical Oncology · 48

Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial

2025 · Chunmei Bai, Yi Zheng, et al. · European Journal of Cancer · 18

A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer.

2024 · Chunmei Bai, Junli Xue, et al. · Journal of Clinical Oncology · 17

High-Sensitivity Detection of Carbon Fiber-Reinforced Polymer Delamination Using a Novel Eddy Current Probe

2024 · Yingni Zhou, Bo Ye, et al. · Applied Sciences · 11

Efficacy and safety of cafelkibart (LM-108), an anti-CCR8 monoclonal antibody, in combination with anti-PD-1 therapy in patients with pancreatic cancer: Results from phase 1/2 studies.

2025 · Jifang Gong, Chang Liu, et al. · Journal of Clinical Oncology · 4

Biplane Enhancement Coil for Magnetic Induction Tomography of Cerebral Hemorrhage

2024 · Zhongkai Cao, Bo Ye, et al. · Biosensors · 3

Current research advances in high-overload-resistant multimode strapdown optoelectronic systems

2025 · wei wang, Dli Zhao, et al. · 1

Works count: 8

Citation count: 101

H-index: 4

I10-index: 4